From: Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Protein | Controls | PD | MSA |
---|---|---|---|
CCL28 | 0.6 ± 0.2b | 0.9 ± 0.2a | 0.8 ± 0.2 |
IL-8 | 8.4 ± 1.3bc | 7.6 ± 0.5a | 7.5 ± 0.4a |
FGF-19 | 4.7 ± 0.8c | 4.2 ± 0.6 | 3.9 ± 0.7a |
CD40 | 8.1 ± 0.5c | 7.6 ± 0.4 | 7.5 ± 0.4a |
PD-L1 | 4.1 ± 0.6c | 3.7 ± 0.5 | 3.5 ± 0.4a |
TGF-α | 6.0 ± 0.6c | 5.7 ± 0.4 | 5.5 ± 0.4a |
SCF | 5.2 ± 0.7c | 4.8 ± 0.5 | 4.7 ± 0.3a |
CSF-1 | 6.9 ± 0.5c | 6.5 ± 0.4 | 6.3 ± 0.2a |
uPA | 6.0 ± 0.6c | 7.0 ± 0.5 | 6.8 ± 0.4a |
VEGF-A | 9.6 ± 0.7c | 9.1 ± 0.6 | 8.9 ± 0.4a |
CCL23 | 3.1 ± 1.0bc | 2.5 ± 0.5a | 2.5 ± 0.3a |
CX3CL1 | 3.2 ± 0.6bc | 2.6 ± 0.5a | 2.4 ± 0.3a |
MCP-2 | 5.0 ± 0.9bc | 4.2 ± 0.8a | 4.2 ± 0.5a |
CXCL1 | 6.0 ± 1.2bc | 4.9 ± 0.5a | 4.9 ± 0.6a |
DNER | 10.0 ± 0.2c | 9.9 ± 0.2c | 9.8 ± 0.1ab |
β-NGF | 1.8 ± 0.5c | 1.5 ± 0.3c | 1.3 ± 0.2ab |